Lydia Ann Fusetti, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 |
David Finnigan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 |
James M Nusrala, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 |
Dr. Ilana F. Dickson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 777 Nw 9th St, Suite 320, Corvallis, OR 97330 Phone: 541-768-4900 Fax: 541-768-4901 |
Dr. Katherine R Long, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 Fax: 541-753-1789 |
Ms. Veneta V Vanguelova, D.O Pediatrics Medicare: Medicare Enrolled Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 |
Kenneth Michael Carlson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 121 Se Viewmont Ave, Corvallis, OR 97333 Phone: 541-766-3546 Fax: 541-766-6143 |
News Archive
Patient Advocate Foundation (PAF) - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - is pleased to announce that it has received additional funding support for serving patients with multiple myeloma through its Co-Pay Relief Program (CPR).
COHRED holds semi-annual Colloquia to bring together a range of stakeholders - from researchers and policymakers to industry representatives and NGOS - to have a free and frank discussion about salient global health issues.
One of the major challenges in stem cell transplants is how to obtain sufficient numbers of these remarkably rare cells to put into patients. To help overcome this issue, research from the Centenary Institute, Royal Prince Alfred Hospital and the University of Sydney has found a way to increase the number of blood-forming stem cells when growing them outside of the body.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
› Verified 3 days ago